Industry Research Reports

Home > Reports > Food & Beverages > Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Food & Beverages

Published Date: 2025-08-05

Pages: 152 Pages

Report ld: 4879986

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Bifidus market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.

From a downstream perspective, Food & Beverages accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Bifidus leading manufacturers including Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma, Shandong Zhongke Jiayi Bioengineering, Danone, etc., dominate supply; the top five capture approximately % of global revenue, with Chr-Hansen leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bifidus market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Food Grade
Pharmaceutical Grade

Segment by Application

Food & Beverages
Medicines
Health Products
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Bifidus study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Bifidus: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Bifidus Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Food Grade

1.2.3 Pharmaceutical Grade

1.3 Market Segmentation by Application

1.3.1 Global Bifidus Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Food & Beverages

1.3.3 Medicines

1.3.4 Health Products

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Bifidus Revenue Estimates and Forecasts 2020-2031

2.2 Global Bifidus Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Bifidus Sales Estimates and Forecasts 2020-2031

2.4 Global Bifidus Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Bifidus Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Bifidus Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Food Grade Market Size by Manufacturers

3.5.2 Pharmaceutical Grade Market Size by Manufacturers

3.6 Global Bifidus Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Bifidus Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Bifidus Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Bifidus Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Bifidus Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Bifidus Sales and Revenue by Type (2020-2031)

6.4 North America Bifidus Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Bifidus Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Bifidus Sales and Revenue by Type (2020-2031)

7.4 Europe Bifidus Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Bifidus Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Bifidus Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Bifidus Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Bifidus Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Bifidus Sales and Revenue by Type (2020-2031)

9.4 Central and South America Bifidus Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Bifidus Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Bifidus Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Bifidus Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Bifidus Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Chr-Hansen

11.1.1 Chr-Hansen Corporation Information

11.1.2 Chr-Hansen Business Overview

11.1.3 Chr-Hansen Bifidus Product Models, Descriptions and Specifications

11.1.4 Chr-Hansen Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Chr-Hansen Bifidus Sales by Product in 2024

11.1.6 Chr-Hansen Bifidus Sales by Application in 2024

11.1.7 Chr-Hansen Bifidus Sales by Geographic Area in 2024

11.1.8 Chr-Hansen Bifidus SWOT Analysis

11.1.9 Chr-Hansen Recent Developments

11.2 DuPont

11.2.1 DuPont Corporation Information

11.2.2 DuPont Business Overview

11.2.3 DuPont Bifidus Product Models, Descriptions and Specifications

11.2.4 DuPont Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 DuPont Bifidus Sales by Product in 2024

11.2.6 DuPont Bifidus Sales by Application in 2024

11.2.7 DuPont Bifidus Sales by Geographic Area in 2024

11.2.8 DuPont Bifidus SWOT Analysis

11.2.9 DuPont Recent Developments

11.3 Wecare Probiotics

11.3.1 Wecare Probiotics Corporation Information

11.3.2 Wecare Probiotics Business Overview

11.3.3 Wecare Probiotics Bifidus Product Models, Descriptions and Specifications

11.3.4 Wecare Probiotics Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Wecare Probiotics Bifidus Sales by Product in 2024

11.3.6 Wecare Probiotics Bifidus Sales by Application in 2024

11.3.7 Wecare Probiotics Bifidus Sales by Geographic Area in 2024

11.3.8 Wecare Probiotics Bifidus SWOT Analysis

11.3.9 Wecare Probiotics Recent Developments

11.4 Probi

11.4.1 Probi Corporation Information

11.4.2 Probi Business Overview

11.4.3 Probi Bifidus Product Models, Descriptions and Specifications

11.4.4 Probi Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Probi Bifidus Sales by Product in 2024

11.4.6 Probi Bifidus Sales by Application in 2024

11.4.7 Probi Bifidus Sales by Geographic Area in 2024

11.4.8 Probi Bifidus SWOT Analysis

11.4.9 Probi Recent Developments

11.5 Mitushi Bio Pharma

11.5.1 Mitushi Bio Pharma Corporation Information

11.5.2 Mitushi Bio Pharma Business Overview

11.5.3 Mitushi Bio Pharma Bifidus Product Models, Descriptions and Specifications

11.5.4 Mitushi Bio Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Mitushi Bio Pharma Bifidus Sales by Product in 2024

11.5.6 Mitushi Bio Pharma Bifidus Sales by Application in 2024

11.5.7 Mitushi Bio Pharma Bifidus Sales by Geographic Area in 2024

11.5.8 Mitushi Bio Pharma Bifidus SWOT Analysis

11.5.9 Mitushi Bio Pharma Recent Developments

11.6 Scitop Bio-tech

11.6.1 Scitop Bio-tech Corporation Information

11.6.2 Scitop Bio-tech Business Overview

11.6.3 Scitop Bio-tech Bifidus Product Models, Descriptions and Specifications

11.6.4 Scitop Bio-tech Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Scitop Bio-tech Recent Developments

11.7 Lallemand

11.7.1 Lallemand Corporation Information

11.7.2 Lallemand Business Overview

11.7.3 Lallemand Bifidus Product Models, Descriptions and Specifications

11.7.4 Lallemand Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Lallemand Recent Developments

11.8 Goerlich Pharma

11.8.1 Goerlich Pharma Corporation Information

11.8.2 Goerlich Pharma Business Overview

11.8.3 Goerlich Pharma Bifidus Product Models, Descriptions and Specifications

11.8.4 Goerlich Pharma Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Goerlich Pharma Recent Developments

11.9 Shandong Zhongke Jiayi Bioengineering

11.9.1 Shandong Zhongke Jiayi Bioengineering Corporation Information

11.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview

11.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Product Models, Descriptions and Specifications

11.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments

11.10 Danone

11.10.1 Danone Corporation Information

11.10.2 Danone Business Overview

11.10.3 Danone Bifidus Product Models, Descriptions and Specifications

11.10.4 Danone Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Danone Recent Developments

11.11 Shanghai SPH Sinopharm

11.11.1 Shanghai SPH Sinopharm Corporation Information

11.11.2 Shanghai SPH Sinopharm Business Overview

11.11.3 Shanghai SPH Sinopharm Bifidus Product Models, Descriptions and Specifications

11.11.4 Shanghai SPH Sinopharm Bifidus Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Shanghai SPH Sinopharm Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Bifidus Industry Chain

12.2 Bifidus Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Bifidus Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Bifidus Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Bifidus Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Bifidus Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Bifidus Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Bifidus Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Bifidus Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Bifidus Sales by Region (2020-2025) & (K Units)

Table 8. Global Bifidus Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Bifidus Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Bifidus Sales Share by Manufacturers (2020-2025)

Table 12. Global Bifidus Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Bifidus Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Bifidus by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidus as of 2024)

Table 16. Global Bifidus Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Bifidus Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Bifidus Manufacturing Base and Headquarters

Table 19. Global Bifidus Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Bifidus Sales by Type (2020-2025) & (K Units)

Table 23. Global Bifidus Sales by Type (2026-2031) & (K Units)

Table 24. Global Bifidus Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Bifidus Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Bifidus ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Bifidus Sales by Application (2020-2025) & (K Units)

Table 29. Global Bifidus Sales by Application (2026-2031) & (K Units)

Table 30. Bifidus High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Bifidus Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Bifidus Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Bifidus ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Bifidus Growth Accelerators and Market Barriers

Table 37. North America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Bifidus Growth Accelerators and Market Barriers

Table 40. Europe Bifidus Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Bifidus Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Bifidus Growth Accelerators and Market Barriers

Table 45. Southeast Asia Bifidus Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Bifidus Investment Opportunities and Key Challenges

Table 47. Central and South America Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Bifidus Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Bifidus Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Chr-Hansen Corporation Information

Table 51. Chr-Hansen Description and Major Businesses

Table 52. Chr-Hansen Product Models, Descriptions and Specifications

Table 53. Chr-Hansen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Chr-Hansen Sales Value Proportion by Product in 2024

Table 55. Chr-Hansen Sales Value Proportion by Application in 2024

Table 56. Chr-Hansen Sales Value Proportion by Geographic Area in 2024

Table 57. Chr-Hansen Bifidus SWOT Analysis

Table 58. Chr-Hansen Recent Developments

Table 59. DuPont Corporation Information

Table 60. DuPont Description and Major Businesses

Table 61. DuPont Product Models, Descriptions and Specifications

Table 62. DuPont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. DuPont Sales Value Proportion by Product in 2024

Table 64. DuPont Sales Value Proportion by Application in 2024

Table 65. DuPont Sales Value Proportion by Geographic Area in 2024

Table 66. DuPont Bifidus SWOT Analysis

Table 67. DuPont Recent Developments

Table 68. Wecare Probiotics Corporation Information

Table 69. Wecare Probiotics Description and Major Businesses

Table 70. Wecare Probiotics Product Models, Descriptions and Specifications

Table 71. Wecare Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Wecare Probiotics Sales Value Proportion by Product in 2024

Table 73. Wecare Probiotics Sales Value Proportion by Application in 2024

Table 74. Wecare Probiotics Sales Value Proportion by Geographic Area in 2024

Table 75. Wecare Probiotics Bifidus SWOT Analysis

Table 76. Wecare Probiotics Recent Developments

Table 77. Probi Corporation Information

Table 78. Probi Description and Major Businesses

Table 79. Probi Product Models, Descriptions and Specifications

Table 80. Probi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Probi Sales Value Proportion by Product in 2024

Table 82. Probi Sales Value Proportion by Application in 2024

Table 83. Probi Sales Value Proportion by Geographic Area in 2024

Table 84. Probi Bifidus SWOT Analysis

Table 85. Probi Recent Developments

Table 86. Mitushi Bio Pharma Corporation Information

Table 87. Mitushi Bio Pharma Description and Major Businesses

Table 88. Mitushi Bio Pharma Product Models, Descriptions and Specifications

Table 89. Mitushi Bio Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Mitushi Bio Pharma Sales Value Proportion by Product in 2024

Table 91. Mitushi Bio Pharma Sales Value Proportion by Application in 2024

Table 92. Mitushi Bio Pharma Sales Value Proportion by Geographic Area in 2024

Table 93. Mitushi Bio Pharma Bifidus SWOT Analysis

Table 94. Mitushi Bio Pharma Recent Developments

Table 95. Scitop Bio-tech Corporation Information

Table 96. Scitop Bio-tech Description and Major Businesses

Table 97. Scitop Bio-tech Product Models, Descriptions and Specifications

Table 98. Scitop Bio-tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Scitop Bio-tech Recent Developments

Table 100. Lallemand Corporation Information

Table 101. Lallemand Description and Major Businesses

Table 102. Lallemand Product Models, Descriptions and Specifications

Table 103. Lallemand Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Lallemand Recent Developments

Table 105. Goerlich Pharma Corporation Information

Table 106. Goerlich Pharma Description and Major Businesses

Table 107. Goerlich Pharma Product Models, Descriptions and Specifications

Table 108. Goerlich Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Goerlich Pharma Recent Developments

Table 110. Shandong Zhongke Jiayi Bioengineering Corporation Information

Table 111. Shandong Zhongke Jiayi Bioengineering Description and Major Businesses

Table 112. Shandong Zhongke Jiayi Bioengineering Product Models, Descriptions and Specifications

Table 113. Shandong Zhongke Jiayi Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Shandong Zhongke Jiayi Bioengineering Recent Developments

Table 115. Danone Corporation Information

Table 116. Danone Description and Major Businesses

Table 117. Danone Product Models, Descriptions and Specifications

Table 118. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Danone Recent Developments

Table 120. Shanghai SPH Sinopharm Corporation Information

Table 121. Shanghai SPH Sinopharm Description and Major Businesses

Table 122. Shanghai SPH Sinopharm Product Models, Descriptions and Specifications

Table 123. Shanghai SPH Sinopharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Shanghai SPH Sinopharm Recent Developments

Table 125. Key Raw Materials Distribution

Table 126. Raw Materials Key Suppliers

Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 128. Milestones in Production Technology Evolution

Table 129. Distributors List

Table 130. Market Trends and Market Evolution

Table 131. Market Drivers and Opportunities

Table 132. Market Challenges, Risks, and Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Bifidus Product Picture

Figure 2. Global Bifidus Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Food Grade Product Picture

Figure 4. Pharmaceutical Grade Product Picture

Figure 5. Global Bifidus Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Food & Beverages

Figure 7. Medicines

Figure 8. Health Products

Figure 9. Others

Figure 10. Bifidus Report Years Considered

Figure 11. Global Bifidus Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Bifidus Revenue (2020-2031) & (US$ Million)

Figure 13. Global Bifidus Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Bifidus Revenue Market Share by Region (2020-2031)

Figure 15. Global Bifidus Sales (2020-2031) & (K Units)

Figure 16. Global Bifidus Sales (CAGR) by Region (2020-2031) (K Units)

Figure 17. Global Bifidus Sales Market Share by Region (2020-2031)

Figure 18. Top 5 and Top 10 Manufacturers Bifidus Sales Volume Market Share in 2024

Figure 19. Global Bifidus Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. Food Grade Revenue Market Share by Manufacturer in 2024

Figure 22. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024

Figure 23. Global Bifidus Sales Market Share by Type (2020-2031)

Figure 24. Global Bifidus Revenue Market Share by Type (2020-2031)

Figure 25. Global Bifidus Sales Market Share by Application (2020-2031)

Figure 26. Global Bifidus Revenue Market Share by Application (2020-2031)

Figure 27. North America Bifidus Sales YoY (2020-2031) & (K Units)

Figure 28. North America Bifidus Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024

Figure 30. North America Bifidus Sales Volume (K Units) by Type (2020- 2031)

Figure 31. North America Bifidus Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 32. North America Bifidus Sales Volume (K Units) by Application (2020-2031)

Figure 33. North America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)

Figure 34. US Bifidus Revenue (2020-2031) & (US$ Million)

Figure 35. Canada Bifidus Revenue (2020-2031) & (US$ Million)

Figure 36. Mexico Bifidus Revenue (2020-2031) & (US$ Million)

Figure 37. Europe Bifidus Sales YoY (2020-2031) & (K Units)

Figure 38. Europe Bifidus Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Europe Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024

Figure 40. Europe Bifidus Sales Volume (K Units) by Type (2020-2031)

Figure 41. Europe Bifidus Sales Revenue (US$ Million) by Type (2020-2031)

Figure 42. Europe Bifidus Sales Volume (K Units) by Application (2020-2031)

Figure 43. Europe Bifidus Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. Germany Bifidus Revenue (2020-2031) & (US$ Million)

Figure 45. France Bifidus Revenue (2020-2031) & (US$ Million)

Figure 46. U.K. Bifidus Revenue (2020-2031) & (US$ Million)

Figure 47. Italy Bifidus Revenue (2020-2031) & (US$ Million)

Figure 48. Russia Bifidus Revenue (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Bifidus Sales YoY (2020-2031) & (K Units)

Figure 50. Asia-Pacific Bifidus Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Top 8 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024

Figure 52. Asia-Pacific Bifidus Sales Volume (K Units) by Type (2020- 2031)

Figure 53. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 54. Asia-Pacific Bifidus Sales Volume (K Units) by Application (2020-2031)

Figure 55. Asia-Pacific Bifidus Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Indonesia Bifidus Revenue (2020-2031) & (US$ Million)

Figure 57. Japan Bifidus Revenue (2020-2031) & (US$ Million)

Figure 58. South Korea Bifidus Revenue (2020-2031) & (US$ Million)

Figure 59. China Taiwan Bifidus Revenue (2020-2031) & (US$ Million)

Figure 60. India Bifidus Revenue (2020-2031) & (US$ Million)

Figure 61. Central and South America Bifidus Sales YoY (2020-2031) & (K Units)

Figure 62. Central and South America Bifidus Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Central and South America Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024

Figure 64. Central and South America Bifidus Sales Volume (K Units) by Type (2021-2031)

Figure 65. Central and South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)

Figure 66. Central and South America Bifidus Sales Volume (K Units) by Application (2020-2031)

Figure 67. Central and South America Bifidus Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Brazil Bifidus Revenue (2020-2025) & (US$ Million)

Figure 69. Argentina Bifidus Revenue (2020-2025) & (US$ Million)

Figure 70. Middle East, and Africa Bifidus Sales YoY (2020-2031) & (K Units)

Figure 71. Middle East and Africa Bifidus Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Middle East and Africa Top 5 Manufacturers Bifidus Sales Revenue (US$ Million) in 2024

Figure 73. Middle East and Africa Bifidus Sales Volume (K Units) by Type (2021-2031)

Figure 74. South America Bifidus Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Middle East and Africa Bifidus Sales Volume (K Units) by Application (2020-2031)

Figure 76. Middle East and Africa Bifidus Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. GCC Countries Bifidus Revenue (2020-2025) & (US$ Million)

Figure 78. Turkey Bifidus Revenue (2020-2025) & (US$ Million)

Figure 79. Egypt Bifidus Revenue (2020-2025) & (US$ Million)

Figure 80. South Africa Bifidus Revenue (2020-2025) & (US$ Million)

Figure 81. Bifidus Industry Chain Mapping

Figure 82. Regional Bifidus Manufacturing Base Distribution (%)

Figure 83. Global Bifidus Production Market Share by Region (2020-2031)

Figure 84. Bifidus Production Process

Figure 85. Regional Bifidus Production Cost Structure

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Bifidus market? zhanKai

The top companies in the global Bifidus market are Chr-Hansen、DuPont、Wecare Probiotics.

Related Reports

Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 166
USD 4900.00
(Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
Bifidus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 111
USD 3950.00
(Single User License)
Global Bifidus Market Research Report 2026
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 123
USD 2900.00
(Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 95
USD 4250.00
(Single User License)
Bifidus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 119
USD 3950.00
(Single User License)
Global Bifidus Market Research Report 2025
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-13
Pages: 90
USD 2900.00
(Single User License)
Global Bifidus Market Research Report 2024
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 89
USD 2900.00
(Single User License)
Global Bifidus Market Insights, Forecast to 2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 157
USD 4900.00
(Single User License)
Global and United States Bifidus Market Report & Forecast 2024-2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published Date: 2024-08-02
Pages: 131
USD 4350.00
(Single User License)

Global Bifidus Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bifidus market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 166
USD 4900.00 (Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bifidus market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
USD 4250.00 (Single User License)
Bifidus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bifidus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 111
USD 3950.00 (Single User License)
Global Bifidus Market Research Report 2026
The global Bifidus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 123
USD 2900.00 (Single User License)
Global Bifidus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bifidus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 95
USD 4250.00 (Single User License)
Bifidus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bifidus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 119
USD 3950.00 (Single User License)
Global Bifidus Market Research Report 2025
The global market for Bifidus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-13
Pages: 90
USD 2900.00 (Single User License)
Global Bifidus Market Research Report 2024
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 89
USD 2900.00 (Single User License)
Global Bifidus Market Insights, Forecast to 2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 157
USD 4900.00 (Single User License)
Global and United States Bifidus Market Report & Forecast 2024-2030
Bifidus is a genus of Gram-positive, non-motile, rod-shaped, sometimes forked, strictly anaerobic bacteria that are widely found in the digestive tract, vagina, and oral cavity of humans and animals. Bifidobacterium probiotics are an important classification of probiotics. They protect intestinal health by regulating the balance of intestinal flora and producing short-chain fatty acids to inhibit the growth of harmful bacteria and the formation of toxic metabolites. In addition, bifidobacteria also have multiple functions such as activating the phagocytic activity of macrophages, inhibiting the growth of tumor cells, and alleviating lactose intolerance.
Published: 2024-08-02
Pages: 131
USD 4350.00 (Single User License)